B. Riley lowered the firm’s price target on Aspen Aerogels (ASPN) to $22 from $35 and keeps a Buy rating on the shares following the Q4 earnings report. B. Riley believes Q1 will represent the trough for the EV business, though commentary from management suggested a cautious approach to the rest of 2025, the analyst tells investors in a research note. The firm believes the stock reflects value of less than $3 per share for the Thermal Barrier business at current levels.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels price target lowered to $13 from $25 at Barclays
- Aspen Aerogels’ Strong 2024 Growth Amid Cautious 2025 Outlook
- Aspen Aerogels price target lowered to $16 from $22 at Roth MKM
- Aspen Aerogels price target lowered to $13 from $32 at Oppenheimer
- Aspen Aerogels price target lowered to $15 from $20 at Canaccord